Article
Modeling Familial MASH by iPSC-Hepatocytes
2025-11-22
Abstract excerpt
Increasing obesity has led to a vast rise in metabolic dysfunction-associated steatotic liver disease (MASLD) in the general population with a significant fraction progressing to metabolic dysfunction-associated steatohepatitis (MASH). Patients with MASH progressively develop inflammation and fibrosis that over time can develop into cirrhosis with an increased risk for hepatocellular carcinoma. Despite the study o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ceb55fef-fdf8-552e-8c7e-11b1c1eabae5
- DOI
- 10.1101/2025.11.18.25338158
